hepat
c
viru
hcv
rna
replic
requir
viral
nonstructur
protein
well
cellular
factor
recent
cellular
protein
synaptotagminbind
cytoplasm
rnainteract
protein
syncrip
also
known
found
bind
hcv
rna
enhanc
hcv
iresdepend
translat
investig
whether
protein
also
involv
hcv
rna
replic
found
syncrip
associ
detergentresist
membran
fraction
coloc
newlysynthes
hcv
rna
knockdown
syncrip
sirna
significantli
decreas
amount
hcv
rna
cell
contain
subgenom
replicon
fulllength
viral
rna
lastli
vitro
replic
assay
immunodeplet
syncrip
show
syncrip
directli
involv
hcv
rna
replic
find
indic
syncrip
dual
function
particip
rna
replic
translat
hcv
life
cycl
hepat
c
viru
hcv
infect
lead
caus
chronic
hepat
liver
cirrhosi
hepatocellular
carcinoma
hcv
envelop
rna
viru
positivestrand
rna
kb
length
reed
rice
encod
larg
polyprotein
process
structur
protein
c
nonstructur
ns
protein
latter
particip
viral
replic
besid
viral
ns
protein
sever
host
factor
includ
human
homologu
vesicleassoci
membran
proteinassoci
protein
gao
et
al
hamamoto
et
al
polypyrimidinetractbind
protein
ptb
aizaki
et
al
chang
luo
domitrovich
et
al
la
antigen
domitrovich
et
al
host
geranylgeranyl
protein
fatti
acid
kapadia
chisari
shown
involv
step
hcv
replic
cycl
host
factor
ptb
la
autoantigen
initi
found
regul
hcv
protein
translat
ali
siddiqui
ito
lai
virtu
bind
region
utr
hcv
rna
later
studi
show
host
factor
also
directli
regul
hcv
rna
replic
either
particip
format
rna
replic
complex
eg
gao
et
al
bind
viral
rna
eg
la
ptb
ali
siddiqui
chang
luo
recent
studi
show
anoth
host
protein
synaptotagminbind
cytoplasm
rnainteract
protein
syncrip
also
name
protein
bind
ntermin
core
proteincod
region
hcv
rna
enhanc
hcv
intern
ribosom
entri
site
ire
depend
translat
kim
et
al
syncrip
member
cellular
heterogen
nuclear
ribonucleoprotein
hnrnp
famili
ptb
also
belong
hnrnp
wellknown
abil
bind
cellular
protein
rna
facilit
mani
biolog
process
interestingli
syncrip
previous
shown
involv
cellular
process
also
mous
hepat
viru
mhv
rna
replic
choi
mizutani
lai
sinc
syncrip
bind
hcv
rna
site
close
rna
like
syncrip
may
also
affect
rna
replic
hcv
case
syncrip
duel
function
rna
replic
protein
translat
similar
duelpurpos
hnrnp
ptb
goal
studi
investig
whether
syncrip
involv
hcv
rna
replic
addit
role
translat
cell
grown
dulbecco
modifi
eagl
medium
dmem
supplement
fetal
bovin
serum
fb
nonessenti
amino
acid
huhhyg
replicon
cell
harbor
hcv
subgenom
replicon
rna
deriv
hcvn
strain
guo
bichko
seeger
grown
medium
contain
mgml
hygromycin
mizutani
et
al
primari
antibodi
use
analys
studi
sheep
antibrdu
polyclon
antibodi
boidesign
mous
antibrdu
monoclon
antibodi
caltag
ca
anticalnexin
monoclon
antibodi
abcam
monoclon
antibodi
abcam
brefeldin
nocodazol
purchas
sigma
actinomycin
fisher
polyclon
antisyncrip
antibodi
gener
rabbit
peptid
amino
acid
inject
mizutani
et
al
label
de
novosynthes
viral
rna
immunofluoresc
stain
confoc
microscopi
modifi
previous
describ
procedur
kanestrom
et
al
briefli
replicon
cell
plate
chamber
slide
densiti
cell
per
well
two
day
seed
cell
incub
actinomycin
hour
inhibit
cellular
rna
synthesi
subsequ
mm
bromouridin
triphosph
brutp
transfect
cell
minut
use
fugen
transfect
reagent
accord
manufactur
instruct
roch
molecular
biochem
cell
wash
phosphatebuff
salin
pb
twice
cultur
differ
incub
durat
dmem
supplement
fb
incub
cell
wash
twice
pb
subsequ
fix
formaldehyd
hour
permeabil
cell
treat
triton
sigmaaldrich
st
loui
mo
pb
supplement
fb
minut
room
temperatur
primari
antibodi
dilut
pb
contain
bovin
serum
albumin
bsa
incub
cell
hour
room
temperatur
three
wash
pb
cell
incub
fluorescein
isothiocyan
fitc
conjug
rhodamineconjug
secondari
antibodi
dilut
pb
contain
bsa
hour
room
temperatur
cell
wash
three
time
pb
mount
vectashield
vector
laboratori
burlingam
ca
membran
flotat
assay
perform
previous
describ
mizutani
et
al
briefli
cell
first
lyse
ml
hypoton
buffer
mm
trishcv
ph
mm
kcl
mm
mgcl
pass
needl
time
nuclei
unbroken
cell
remov
centrifug
minut
microcentrifug
cell
lysat
mix
ml
sucros
lowsalt
buffer
lsb
compris
mm
trishcl
ph
mm
kcl
mm
mgcl
overlaid
ml
sucros
lsb
follow
ml
sucros
lsb
sucros
gradient
centrifug
rpm
beckman
ti
rotor
hour
centrifug
fraction
taken
top
gradient
ad
ml
lsb
dilut
sucros
concentr
pass
centricon
filter
unit
millipor
bedford
one
half
sucros
gradient
fraction
separ
sdspage
transfer
nitrocellulos
membran
block
membran
incub
primari
antibodi
h
follow
appropri
speciesspecif
horseradish
peroxidas
conjug
addit
h
bound
antibodi
detect
eclplu
system
amersham
piscataway
nj
sirna
sycrip
sequenc
locat
nt
respect
syncrip
open
read
frame
orf
synthes
integr
dna
technolog
inc
coralvil
iw
sirna
design
target
two
differ
site
human
syncrip
gene
chosen
sirna
target
finder
softwar
ambion
http
wwwambioncomtechlibmiscsirnafinderhtml
choi
mizutani
lai
replicon
cell
grown
fbsdmem
without
antibiot
transfect
cell
plate
densiti
cell
per
well
plate
day
three
stock
sirna
duplex
mix
optimem
invitrogen
ca
day
separ
tube
lipofectamin
invitrogen
ca
resuspend
optimem
follow
incub
rt
min
two
mixtur
combin
allow
sit
rt
min
incub
optimem
ad
mixtur
directli
ad
well
contain
growth
medium
day
cell
trypsin
split
well
plate
day
cell
retransfect
use
sirna
lipofectamin
day
cell
harvest
either
western
blot
analysi
rna
isol
contain
fulllength
hcv
rna
hybrid
sequenc
genotyp
control
polymeras
promot
describ
previous
fulllength
hcv
rna
vitro
transcrib
promot
obtain
positivesens
hcv
rna
kb
hcv
fulllength
rna
transfect
cell
one
day
sirna
retransfect
miru
transit
mrna
transfect
reagent
miru
bio
wi
briefli
booster
reagent
transit
reagent
ad
optimem
sequenti
follow
vitro
transcrib
hcv
rna
mixtur
incub
min
rt
ad
well
plate
contain
ml
fresh
dmem
supplement
fb
cellular
rna
isol
well
day
hcv
rna
transfect
cell
lysat
replicon
control
cell
prepar
modifi
protocol
ali
tardif
siddiqui
cell
grown
dish
wash
cold
wash
buffer
mm
sucros
mm
hepe
ph
mm
ammonium
chlorid
mm
kcl
mm
magnesium
acet
follow
treatment
lysolecithin
buffer
wash
buffer
min
three
millilit
wash
buffer
ad
cultur
plate
buffer
remov
aspir
cell
collect
scrape
incomplet
replic
buffer
mm
hepe
ph
mm
ammonium
chlorid
mm
potassium
chlorid
mm
spermidin
mm
atp
gtp
utp
ctp
transfer
new
tube
lyse
gentli
pipet
time
cell
suspens
centrifug
rpm
microcentrifug
min
immunodeplet
experi
cytoplasm
fraction
supernat
obtain
treat
nonidet
boehring
mannheim
quebec
canada
hr
incub
indic
antibodi
adjust
amount
pb
hr
rotat
incub
sampl
incub
pctp
cimmol
actinomycin
per
ml
u
rnase
inhibitor
per
ml
promega
corpor
wi
hr
extract
rna
total
mixtur
perform
tri
regent
molecular
research
center
inc
cincinnati
oh
rna
precipit
elut
rnasefre
water
replic
product
analyz
gel
electrophoresi
formaldehyd
agaros
gel
shown
hcv
rna
replic
occur
detergentresist
membran
drm
fraction
ali
tardif
siddiqui
elhag
luo
mizutani
et
al
nonstructur
protein
hcv
associ
drm
structur
contain
strongli
suggest
viral
replic
complex
properti
lipid
raft
gao
et
al
mizutani
et
al
determin
whether
syncrip
rna
replic
complex
perform
membran
flotat
analysi
hcv
replicon
cell
follow
immunoblot
antisyncrip
antibodi
examin
possibl
presenc
syncrip
detergentresist
membran
fraction
hcv
replic
complex
resid
found
syncrip
present
mostli
cytosol
fraction
fraction
fig
cell
small
fraction
associ
membran
fraction
fig
treatment
triton
syncrip
still
associ
membran
cell
contrast
almost
syncrip
solubil
cell
longer
exposur
immunoblot
perform
syncrip
still
found
drm
fraction
treat
cell
control
calnexin
marker
protein
er
membran
concentr
exclus
membran
fraction
fraction
absenc
deterg
treatment
cell
fig
panel
cell
treat
cold
deterg
calnexin
redistribut
entir
solubl
fraction
indic
calnexin
associ
detergentsolubl
membran
known
characterist
unmodifi
er
data
suggest
syncrip
predominantli
cytoplasm
protein
reloc
drm
fraction
fraction
treatment
replicon
cell
reloc
syncrip
protein
calnexin
drm
fraction
replicon
cell
indic
syncrip
may
specif
recruit
hcv
rna
replic
complex
sinc
syncrip
bind
hcv
rna
kim
et
al
previou
studi
hcv
replicon
cell
shown
newli
synthes
hcv
rna
viral
nonstructur
protein
coloc
distinct
specklelik
structur
cytoplasm
replicon
cell
gosert
et
al
mizutani
et
al
examin
whether
syncrip
associ
hcv
rna
synthesi
speckl
structur
brutp
label
perform
hcv
replicon
cell
transfect
pegfpsyncrip
gift
dr
mizutani
univers
tokyo
briefli
two
day
transfect
pegfpsyncrip
brutp
transfect
actinomycin
dpretreat
cell
kanestrom
et
al
immunofluoresc
stain
sheep
antibrdu
polyclon
antibodi
biodesign
perform
kanestrom
et
al
condit
brulabel
repres
hcv
rna
sinc
cellular
transcript
inhibit
actinomycin
treatment
brulabel
rna
present
either
distinct
specklelik
structur
larg
spheric
particl
cytoplasm
replicon
cell
fig
consist
previou
report
mizutani
et
al
two
pattern
probabl
repres
two
differ
state
viral
rna
synthesi
brulabel
rna
found
cell
without
hcv
replicon
syncrip
also
local
cytoplasm
cell
without
hcv
replicon
diffus
pattern
bru
label
hcv
replicon
cell
found
egfpsyncrip
partial
coloc
brulabel
rna
replicon
cell
fig
indic
portion
syncrip
recruit
hcv
rna
replic
site
find
consist
fraction
profil
show
syncrip
primarili
cytosol
protein
portion
syncrip
reloc
drm
fraction
replicon
cell
fig
phenomenon
also
observ
ptb
replicon
cell
aizaki
et
al
small
portion
ptb
reloc
cytoplasm
wherea
major
remain
nucleu
result
suggest
portion
syncrip
local
hcv
replic
complex
impli
syncrip
involv
hcv
rna
replic
determin
biolog
role
syncrip
hcv
rna
replic
monitor
hcv
rna
level
hcv
replicon
cell
endogen
syncrip
knock
rna
interfer
method
aizaki
et
al
wagner
garciablanco
huhhyg
replicon
cell
transfect
either
syncripspecif
sirna
choi
mizutani
lai
nonspecif
ns
sirna
protein
analysi
immunoblot
perform
rabbit
polyclon
antisyncrip
antibodi
hcv
rna
level
monitor
use
taqman
quantit
realtim
rtpcr
gao
et
al
cell
transfect
syncrip
sirna
show
signific
reduct
endogen
syncrip
day
posttransfect
fig
one
day
retransfect
sirna
respect
almost
endogen
syncrip
could
detect
fig
correspondingli
syncrip
sirnatransfect
hcv
replicon
cell
show
reduct
hcv
rna
day
retransfect
sirna
compar
cell
transfect
nonspecif
sirna
fig
lag
time
one
day
drop
syncrip
hcv
rna
probabl
due
rel
stabil
hcv
rna
replicon
cell
also
use
confirm
result
obtain
use
huhhyg
replicon
cell
syncrip
knockdown
achiev
sirna
transfect
viral
protein
rna
level
examin
timecours
studi
nonspecif
sirna
significantli
affect
syncrip
express
express
level
syncrip
dramat
decreas
transfect
specif
sirna
syncrip
sirna
fig
correspondingli
decreas
intracellular
replicon
rna
detect
day
pt
fig
decreas
express
also
detect
sirna
cell
howev
viral
protein
decreas
day
sirna
transfect
fig
result
suggest
syncrip
affect
hcv
rna
translat
rna
replic
exert
effect
differ
mechan
report
syncrip
interact
hcv
rna
fragment
span
nt
correspond
nterminu
core
proteincod
region
kim
et
al
sinc
region
immedi
downstream
neomycinphosphotransferas
gene
hcv
replicon
possibl
observ
involv
syncrip
replicon
cell
due
possibl
effect
syncrip
express
phosphotransferas
rule
possibl
examin
role
syncrip
replic
hcv
fulllength
rna
without
neomycin
phosphotransferas
gene
cell
first
transfect
retransfect
syncripspecif
sirna
knock
endogen
syncrip
protein
one
day
retransfect
sirna
cell
transfect
replicationcompet
fulllength
hcv
rna
syncrip
express
level
sirnatransfect
cell
examin
immunoblot
syncrip
express
significantli
decreas
cell
transfect
specif
sirna
sirna
fig
correspondingli
express
also
affect
specif
syncrip
sirna
sirna
cell
detect
first
day
posttransfect
hcv
fulllength
rna
becam
undetect
thereaft
wherea
nonspecif
sirnatransfect
cell
detect
day
hcv
rna
transfect
fig
total
intracellular
hcv
rna
determin
variou
day
quantit
realtim
rtpcr
cell
transfect
nonspecif
sirna
hcv
rna
titer
gradual
increas
first
hr
posttransfect
agreement
publish
report
fig
contrast
cell
transfect
syncripspecif
sirna
hcv
rna
titer
decreas
steadili
period
time
fig
although
detect
first
day
hcv
rna
transfect
syncripknock
cell
fig
sign
hcv
replic
fig
intracellular
hcv
rna
level
normal
express
level
shown
fig
regardless
express
detect
syncrip
knockdown
cell
hcv
rna
titer
constantli
decreas
fulllength
hcv
rna
transfect
slight
increas
intracellular
hcv
rna
level
day
posttransfect
hcv
fulllength
rna
probabl
due
increas
syncrip
protein
level
result
suggest
endogen
syncrip
directli
involv
hcv
replic
suppress
express
neomycin
phosphotransferas
gene
result
combin
indic
syncrip
involv
hcv
replic
affect
either
hcv
rna
replic
translat
sirna
knockdown
approach
show
syncrip
protein
level
decreas
hcv
rna
titer
would
correspondingli
decreas
sinc
syncrip
shown
directli
involv
hcv
translat
kim
et
al
inhibit
hcv
rna
replic
syncripknockdown
cell
may
result
indirect
effect
inhibit
translat
name
viral
ns
protein
synthesi
inhibit
therebi
viral
rna
synthesi
decreas
distinguish
effect
syncrip
rna
replic
translat
design
experi
separ
viral
rna
replic
viral
translat
employ
vitro
replic
assay
use
crude
membran
fraction
hcv
subgenom
replicon
cell
ali
tardif
siddiqui
gao
et
al
endogen
syncrip
knock
sirna
approach
also
perform
vitro
rna
replic
assay
syncrip
deplet
antisyncrip
antibodi
cell
lysat
immunoblot
show
amount
syncrip
replicon
cell
substanti
reduc
specif
sirna
treatment
two
day
fig
time
amount
partial
reduc
cell
lysat
sirnatransfect
replicon
cell
treat
minut
fraction
sucros
gradient
centrifug
isol
drm
fraction
aizaki
et
al
ali
tardif
siddiqui
drm
fraction
cell
lysat
use
vitro
replic
assay
hcv
rna
synthesi
detect
singl
band
plabel
rna
result
show
detect
rna
replic
activ
drm
fraction
syncrip
sirnatransfect
replicon
cell
compar
nontransfect
nonspecif
sirnatransfect
replicon
cell
fig
sinc
still
signific
amount
remain
sirnatransfect
cell
total
lack
vitro
replic
activ
syncrip
knockeddown
replicon
cell
suggest
direct
role
syncrip
hcv
rna
replic
perform
immunodeplet
experi
remov
syncrip
form
drm
fraction
assess
effect
hcv
rna
replic
vitro
immunodeplet
drm
fraction
replicon
cell
lysat
incub
rabbit
antisyncrip
polyclon
antibodi
deplet
endogen
syncrip
lysat
incub
sampl
use
cellfre
synthesi
hcv
rna
result
show
treatment
antisyncrip
antibodi
inhibit
replic
activ
antibodi
concentrationdepend
manner
wherea
control
antiig
antibodi
inhibit
activ
even
higher
antibodi
concentr
fig
data
shown
control
vapa
antibodi
also
inhibit
hcv
rna
replic
similar
previou
result
hamamoto
et
al
wherea
anticalnexin
antibodi
result
combin
suggest
syncrip
directli
involv
hcv
rna
replic
addit
role
regul
translat
hcv
rna
sinc
syncrip
coloc
newli
synthes
hcv
rna
like
syncrip
part
hcv
rna
replic
complex
particip
viral
rna
synthesi
result
show
syncrip
modul
hcv
rna
replic
previous
report
syncrip
also
enhanc
hcv
iresdepend
translat
kim
et
al
thu
similar
ptb
la
autoantigen
syncrip
dual
function
hcv
life
cycl
may
common
characterist
hcv
rnabind
protein
studi
reloc
syncrip
drm
fraction
hcv
replicon
cell
indic
syncrip
associ
rna
replic
complex
local
membran
fraction
interest
note
distribut
calnexin
slightli
differ
control
replicon
cell
shift
calnexin
toward
lighter
sucros
gradient
fraction
probabl
case
alter
cellular
membran
structur
associ
hcv
ns
protein
er
membran
structur
hcv
replicon
cell
egger
et
al
elhag
luo
gosert
et
al
mottola
et
al
nevertheless
syncrip
clearli
local
drm
fraction
wherea
calnexin
immunodeplet
experi
current
previou
studi
shown
antibodi
ptb
hvapa
hvapb
syncrip
inhibit
hcv
rna
replic
activ
specif
previou
studi
suggest
hcv
rna
replic
complex
protein
complex
newlysynthes
rna
contain
within
yang
et
al
subtilisin
proteas
treatment
could
disrupt
replic
complex
howev
also
report
hcv
replic
complex
resist
proteinas
k
treatment
room
temperatur
quinkert
bartenschlag
lohmann
latter
studi
suggest
hcv
replic
complex
compact
therefor
access
immunoglobulin
specif
protein
target
replic
complex
may
limit
howev
abil
antibodi
inhibit
hcv
rna
replic
suggest
complex
may
compact
access
immunoglobulin
molecul
condit
genom
positivestrand
rna
virus
hcv
polioviru
coronaviru
serv
templat
translat
synthesi
negativestrand
rna
latter
turn
templat
synthes
positivestrand
rna
positivestrand
rna
also
packag
form
new
viral
particl
sinc
positivestrand
rna
particip
differ
step
viral
life
cycl
tempor
spatial
regul
import
like
regul
rnaprotein
interact
complex
specif
rnp
rna
util
specif
differ
step
limit
number
gene
viral
genom
regul
like
requir
particip
variou
host
factor
interact
viral
rna
viral
protein
mani
known
host
viral
rnabind
protein
facilit
positivestrand
rna
replic
tat
protein
bind
tar
structur
rna
dingwal
et
al
wagner
garciablanco
poli
rc
bind
protein
bind
cloverleaf
structur
polioviru
rna
blyn
et
al
gamarnik
andino
howev
mani
rnabind
protein
report
dual
function
viral
rna
replic
translat
recent
la
ptb
found
regul
rna
replic
translat
hcv
probabl
result
abil
bind
hcv
rna
aizaki
et
al
domitrovich
et
al
host
factor
dualregulatori
function
may
play
import
role
switch
rna
translat
replic
replic
translat
exampl
pcbp
regul
translationrepl
switch
polioviru
life
cycl
back
et
al
gamarnik
andino
report
previous
stemloop
ii
critic
hcv
rna
replic
stemloop
ii
iii
iv
import
hcv
rna
translat
elhag
luo
fukushi
et
al
qi
et
al
la
autoantigen
shown
bind
loop
iv
hcv
ali
siddiqui
although
evid
la
bind
stemloop
ii
la
nevertheless
regul
hcv
replic
domitrovich
et
al
similarli
syncrip
report
bind
nt
kim
et
al
region
essenti
hcv
iresdriven
translat
hcv
replic
yet
found
signific
posit
regulatori
effect
syncrip
hcv
rna
replic
possibl
bind
syncrip
hcv
rna
alter
secondari
structur
rna
recruit
requir
factor
facilit
assembl
replic
complex
mechan
switch
translat
replic
hcv
rna
still
unclear
conceiv
may
regul
dualfunct
protein
involv
replic
translat
interest
determin
futur
whether
rel
ratio
protein
may
trigger
switch
cell
lysat
prepar
hcv
replicon
cell
pass
needl
time
nuclei
unbroken
cell
remov
centrifug
g
min
microcentrifug
supernat
treat
without
minut
fraction
discontinu
sucros
gradient
centrifug
fraction
collect
top
number
fraction
concentr
centricon
millipor
immunoblot
rabbit
antisyncrip
antibodi
mous
anticalnexin
antibodi
respect
syncrip
found
membran
solubl
fraction
untreat
cell
wherea
cell
syncrip
local
drm
fraction
phenomenon
seen
calnexin
profil
pegfpsyncrip
transfect
hcv
replicon
cell
fugen
two
day
transfect
hcv
replicon
cell
label
brutp
minut
onehour
treatment
actinomycin
actinomycin
treatment
inhibit
brutp
incorport
cell
left
two
panel
replicon
cell
bru
label
detect
cytoplasm
right
panel
immunofluoresc
stain
perform
sheep
polyclon
antibodi
brdu
antibrdu
follow
rhodamineconjug
antisheep
antibodi
jackson
immunoresearch
two
differ
cell
shown
repres
two
differ
distribut
pattern
brutp
shown
previous
mizutani
et
al
sirna
syncrip
sirna
choi
mizutani
lai
nonspecif
sirna
transfect
hcv
replicon
cell
two
day
first
transfect
sirna
retransfect
cell
ensur
complet
knockdown
syncrip
endogen
syncrip
protein
level
monitor
immunoblot
hcv
rna
level
detect
realtim
rtpcr
b
c
immunoblot
syncrip
express
syncrip
sirna
knockdown
replicon
cell
intracelluar
replicon
rna
level
examin
realtim
rtpcr
one
two
day
retransfect
sirna
sirna
two
differ
clone
sirna
n
nonspecif
sirna
sirna
syncrip
sirna
nonspecif
sirna
transfect
cell
twice
knock
endogen
syncrip
level
describ
fig
one
day
retransfet
sirna
vitro
synthes
fulllength
rna
transfect
sirnatransfect
cell
respect
immunoblot
endogen
syncrip
sirna
retransfect
express
level
variou
day
hcv
rna
transfect
b
intracellular
hcv
rna
level
determin
quantit
rtpcr
c
intracellular
hcv
rna
level
normal
express
level
cell
transfect
syncripspecif
nonspecif
sirna
one
day
sirna
transfect
replicationcompet
fulllength
hcv
rna
transfect
cell
hcv
rna
level
detect
realtim
rtpcr
differ
day
hcv
rna
transfect
rel
amount
hcv
rna
express
fig
syncrip
knock
transfect
two
time
specif
sirna
hcv
replicon
cell
fig
syncrip
gapdh
protein
express
determin
immunoblot
cellfre
rna
replic
assay
use
drm
fraction
isol
cell
lysat
describ
materi
method
perform
pctplabel
hcv
rna
product
detect
autoradiographi
separ
agaros
gel
electrophoresi
nc
nonspecif
sirna
control
syncrip
syncripspecif
sirna
sirna
transfect
b
partial
purifi
lysat
hcv
replicon
cell
incub
antiigg
antisyncrip
antivapa
anticalnexin
antibodi
sampl
incub
pctp
cellfre
rnadepend
rna
polymeras
assay
rna
product
separ
formaldehyd
agaros
gel
identifi
autoradiographi
